Flow Cytometry Immunophenotyping (FCI) of Fine Needle Aspirates (FNAs) of Lymph Nodes

被引:1
|
作者
Paro, Mirjana Mariana Kardum [1 ]
Siftar, Zoran [1 ]
Kardum-Skelin, Ika [2 ,3 ]
Sustercic, Dunja [2 ]
Nazor, Aida [1 ]
Flegar-Mestric, Zlata [1 ,4 ]
Jaksic, Branimir [3 ]
机构
[1] Merkur Univ Hosp, Inst Clin Chem, Zagreb, Croatia
[2] Merkur Univ Hosp, Lab Cytol & Hematol, Dept Med, Zagreb, Croatia
[3] Univ Zagreb, Sch Med, Zagreb 41001, Croatia
[4] Univ Zagreb, Fac Pharm & Biochem, Zagreb 41000, Croatia
关键词
flow cytometry immunophenotyping (FCI); fine needle aspirates (FNAs); CANADIAN CONSENSUS RECOMMENDATIONS; NON-HODGKINS-LYMPHOMAS; HEMATOLOGIC NEOPLASIA; CYTOLOGIC SPECIMENS; DIAGNOSIS; LIGHT; LIMITATIONS; DISEASES; BLOOD;
D O I
暂无
中图分类号
Q98 [人类学];
学科分类号
030303 ;
摘要
Flow cytometry immunophenotyping (FCI) has an important role in the clinic work-up of fine needle aspirates (FNAs) of lymph nodes. Its standardization has been defined by proposed analytical protocols and procedures used to assure proper analytical results also in those non-routine samples. In Institute of Clinical Chemistry, "Merkur" University Hospital, FCI is accredited method according to laboratory accreditation standard ISO 15189. According to this laboratory accreditation standard, participation in external quality assessment (EQA) programs is a prerequisite for assuring integrity and quality of the entire laboratory process. A critical analysis of our institutional experience in the feasibility of FCI of the material obtained by FNA of lymph nodes with suspected lymphoma represented the purpose of the study. During an eight-year period in Institute of Clinical Chemistry, "Merkur" University Hospital, a total of 1295 FNA analysis was done, 245 of them with a possible diagnosis of B-cell Non-Hodgkin lymphomas (B-NHL) formed the basis of the study. Lymphocytes were isolated on density gradient according to Boyum et al. The average feasibility of FNAs for FCI analysis was 86 % (ranged 78-93%). An acceptable total cell number in FNAs for FCI analysis (4257) was established. In total population of respondents statistical significances in expressions of cellular antigens CD3, CD5, CD22, CD23, CD19 and CD5 on B-cells (CD5 + CD19 +) between patient's with final diagnosis of benign, reactive lymphoid proliferations and patient 's with diagnosis of B-NHL were found. EQA results analysis showed that all results were either inside target values ((X) over bar+/-1SD) or inside accepted values ((X) over bar+/-2SD). Compatibility of the restriction of imunoglobulins light chains determinated by FCI and cytomorphology diagnosis depends on the choice of criterion values of the light chains ratio which determine the monoclonality. According to the matrix of shares of all classified data of retained neural network, ranges of diagnostic sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and prevalency of 82%, 72%, 93%, 48%, and 72% were produced. As a conclusion, FCI is a reliable methodology for phenotyping FNAs of lymph nodes with suspected B-NHLs detecting their clonality easily.
引用
收藏
页码:359 / 365
页数:7
相关论文
共 50 条
  • [21] Causes of necrotic features in fine-needle aspirates from cervical lymph nodes
    Seo, Young Jin
    Shin, Hyeongchan
    Lee, Hye Won
    Jung, Hye Ra
    JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2021, 55 (01) : 60 - 67
  • [22] DNA FLOW-CYTOMETRY OF BREAST-CANCER FINE NEEDLE ASPIRATES
    REMVIKOS, Y
    BRITISH JOURNAL OF CANCER, 1990, 61 (02) : 343 - 343
  • [23] Normative data for flow cytometry immunophenotyping of benign lymph nodes sampled by surgical biopsy
    Scott, Gregory David
    Atwater, Susan K.
    Gratzinger, Dita A.
    JOURNAL OF CLINICAL PATHOLOGY, 2018, 71 (02) : 174 - 179
  • [24] Assessment of cell proliferation by Ki-67 staining and flow cytometry in fine needle aspirates (FNAs) of reactive lymphadenitis and non-Hodgkin's lymphomas
    Schmitt, F
    Tani, E
    Tribukait, B
    Skoog, L
    CYTOPATHOLOGY, 1999, 10 (02) : 87 - 96
  • [25] Diagnostic role of flow cytometry in fine needle aspiration biopsy of lymph nodes performed for suspected lymphoma.
    Kaleem, Z
    Davila, RM
    Ryan, MR
    Zutter, MM
    Wick, MR
    LABORATORY INVESTIGATION, 1999, 79 (01) : 46A - 46A
  • [26] EVALUATION OF INVIVO BREAST FINE NEEDLE ASPIRATES BY FLOW-CYTOMETRY - AN EFFICACY STUDY
    FUHR, JE
    KATTINE, AA
    NELSON, HS
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (16) : 1272 - 1276
  • [27] FLOW-CYTOMETRY OF LYMPHOID FINE NEEDLE ASPIRATES - AN IMPROVEMENT IN DIAGNOSTIC-ACCURACY
    OMALLEY, F
    CRAMER, H
    BANERJEE, D
    LAMPE, H
    LABORATORY INVESTIGATION, 1990, 62 (01) : A76 - A76
  • [28] Large-scale flow immunophenotyping of benign lymph nodes sampled by fine needle aspiration: representative specimens with diagnostic pitfalls
    Scott, Gregory D.
    Gratzinger, Dita
    LABORATORY INVESTIGATION, 2018, 98 : 173 - 173
  • [29] Large-scale flow immunophenotyping of benign lymph nodes sampled by fine needle aspiration: representative specimens with diagnostic pitfalls
    Scott, Gregory D.
    Gratzinger, Dita
    MODERN PATHOLOGY, 2018, 31 : 173 - 173
  • [30] NTRK, RET, BRAF, and ALK fusions in thyroid fine-needle aspirates (FNAs).
    Wirth, Lori J.
    Hu, Mimi I-Nan
    Waguespack, Steven G.
    Dosiou, Chrysoula
    Ladenson, Paul
    Livhits, Masha J.
    Sadow, Peter M.
    Krane, Jeffrey
    Stack, Brendan C.
    Zafereo, Mark
    Ali, Syed Z.
    Weitzman, Steven P.
    Hao, Yangyang
    Babiarz, Joshua
    Kennedy, Giulia
    Kloos, Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)